Literature DB >> 33493235

Site-specific risk of colorectal neoplasms in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis.

XiaoLi Lin1, FengMing You1, Hong Liu1, Yu Fang1, ShuoGuo Jin1, QiaoLing Wang1.   

Abstract

BACKGROUND: Many studies have shown that NAFLD is indeed closely related to the occurrence of colon tumors. The aim of this study was to further establish an assessment for the risk associated with NAFLD and the site-specificity of colon tumors.
METHODS: We searched the PubMed, Embase, Cochrane, and Scopus databases published from January 1, 1981, to December 15, 2019, assessing the risk of colorectal neoplasms in patients with NAFLD. The primary outcome measure was the incidence of site-specific risk of colorectal neoplasms in patients with NAFLD reported as ORs which pooled under a random-effects model and calculated via Mantel-Haenszel weighting. The study is registered with PROSPERO, number CRD42020162118.
RESULTS: 11 articles (12,081 participants) were included in this meta-analysis. After heterogeneity removed, the overall risk-value pooled for right colon tumors(OR = 1.60,95% CI 1.27-2.01,I2 = 58%,P = 0.02)was higher than the left(OR = 1.39,95% CI 1.11-1.73,I2 = 59%,P = 0.02).However, this outcome was unclear when considering gender differences (Male&Right:OR = 1.05; Male&Left:OR = 1.26; Female&Right: OR = 1.17; Female&Left:OR = 1.17).The incidence of right colon tumors(Asian&Right:OR = 1.56)was obviously higher in Asians with NAFLD than the left (Asian&Left:OR = 1.23),while the risk relevance was similar and moderately associated with an increased risk of incident double-sided colorectal tumors in Europeans (European&Right:OR = 1.47; European&Left:OR = 1.41). The outcome of pathological morphology includes: the advanced adenoma OR = 1.82;the tubular adenoma OR = 1.24;the serrated adenoma OR = 2.16.
CONCLUSIONS: NAFLD is associated with a high risk of colon tumors, especially in regard to tumors of the right colon, which are more prevalent in Asian populations.

Entities:  

Mesh:

Year:  2021        PMID: 33493235      PMCID: PMC7833217          DOI: 10.1371/journal.pone.0245921

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  37 in total

1.  Adipokines and cytokines in non-alcoholic fatty liver disease.

Authors:  I Tasci; T Dogru; C N Ercin; G Erdem; A Sonmez
Journal:  Aliment Pharmacol Ther       Date:  2008-07       Impact factor: 8.171

Review 2.  Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney disease.

Authors:  Giovanni Targher; Christopher D Byrne
Journal:  Nat Rev Nephrol       Date:  2017-02-20       Impact factor: 28.314

Review 3.  The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer.

Authors:  Yan Lv; Nishant Patel; Hai-Jun Zhang
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2019-11-29       Impact factor: 3.869

4.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

Review 5.  Non-alcoholic steatohepatitis: a microbiota-driven disease.

Authors:  Alexander R Moschen; Susanne Kaser; Herbert Tilg
Journal:  Trends Endocrinol Metab       Date:  2013-07-01       Impact factor: 12.015

Review 6.  The association between nonalcoholic fatty liver disease and risk of colorectal adenoma and cancer incident and recurrence: a meta-analysis of observational studies.

Authors:  Jin Chen; Dongxue Bian; Shufei Zang; Zongxing Yang; Guoyan Tian; Yan Luo; Jing Yang; Beibei Xu; Junping Shi
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2019-02-19       Impact factor: 3.869

7.  Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005.

Authors:  Lee Cheng; Cathy Eng; Linda Z Nieman; Asha S Kapadia; Xianglin L Du
Journal:  Am J Clin Oncol       Date:  2011-12       Impact factor: 2.339

8.  Subsite-specific colorectal cancer incidence rates and stage distributions among Asians and Pacific Islanders in the United States, 1995 to 1999.

Authors:  Xiaocheng Wu; Vivien W Chen; Jim Martin; Steven Roffers; Frank D Groves; Catherine N Correa; Elizabeth Hamilton-Byrd; Ahmedin Jemal
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-07       Impact factor: 4.254

9.  Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.

Authors:  Alessandro Mantovani; Marco Dauriz; Christopher D Byrne; Amedeo Lonardo; Giacomo Zoppini; Enzo Bonora; Giovanni Targher
Journal:  Metabolism       Date:  2018-06-20       Impact factor: 8.694

10.  Prognostic role of neutrophil to lymphocyte ratio in lung cancers: a meta-analysis including 7,054 patients.

Authors:  Qing-Tao Zhao; Yong Yang; Shun Xu; Xiao-Peng Zhang; Hui-En Wang; Hua Zhang; Zhi-Kang Wang; Zheng Yuan; Guo-Chen Duan
Journal:  Onco Targets Ther       Date:  2015-09-29       Impact factor: 4.147

View more
  4 in total

1.  Individuals with Metabolic Syndrome Show Altered Fecal Lipidomic Profiles with No Signs of Intestinal Inflammation or Increased Intestinal Permeability.

Authors:  Mia J Coleman; Luis M Espino; Hernan Lebensohn; Marija V Zimkute; Negar Yaghooti; Christina L Ling; Jessica M Gross; Natalia Listwan; Sandra Cano; Vanessa Garcia; Debbie M Lovato; Susan L Tigert; Drew R Jones; Rama R Gullapalli; Neal E Rakov; Euriko G Torrazza Perez; Eliseo F Castillo
Journal:  Metabolites       Date:  2022-05-11

2.  Nonalcoholic fatty liver disease and health outcomes: An umbrella review of systematic reviews and meta-analyses.

Authors:  Lixian Zhong; Chutian Wu; Yuting Li; Qiuting Zeng; Leizhen Lai; Sisi Chen; Shaohui Tang
Journal:  Ther Adv Chronic Dis       Date:  2022-05-19       Impact factor: 4.970

Review 3.  Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and Steatosis or Steatohepatitis.

Authors:  Fausto Petrelli; Michele Manara; Silvia Colombo; Gabriella De Santi; Michele Ghidini; Marco Mariani; Alessandro Iaculli; Emanuele Rausa; Valentina Rampulla; Marcella Arru; Matteo Viti; Veronica Lonati; Antonio Ghidini; Andrea Luciani; Antonio Facciorusso
Journal:  Neoplasia       Date:  2022-05-27       Impact factor: 6.218

Review 4.  Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.

Authors:  Eda Kaya; Yusuf Yilmaz
Journal:  J Clin Transl Hepatol       Date:  2021-10-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.